Sharon F. Hain

18-FDG-PET as a Prognostic Indicator in the Treatment of Aggressive Non-Hodgkin's Lymphoma-Comparison with CT

N. George Mikhaeel, A.R. Timothy, M. J. OʼDoherty et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2000 · 247 citations

FDG–PET. A possible prognostic factor in head and neck cancer

W. Halfpenny, Sharon F. Hain, Lorenzo Biassoni et al. · British Journal of Cancer · 2002 · 205 citations · Full text

Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology

Jan Stauss, Christiane Franzius, Thomas Pfluger et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 188 citations

Positron Emission Tomography, Computed Tomography, Engineering +11

2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: Influence on patient management in a single institution

Savannah C. Partridge, A. Timothy, Michael O’Doherty et al. · Annals of Oncology · 2000 · 171 citations · Full text

Positron Emission Tomography, Pretreatment Staging, Oncologic Imaging +7

<b>Pediatric and Adolescent Lymphoma:</b>Comparison of Whole-Body STIR Half-Fourier RARE MR Imaging with an Enhanced PET/CT Reference for Initial Staging<sup />

Shonit Punwani, Stuart A. Taylor, Alan Bainbridge et al. · Radiology · 2010 · 129 citations